CPH Pharma ApS: Financial statements 2020
CVR: 37110248
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
CPH Pharma ApS (CVR 37110248) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 1,013,451 and a net result of DKK 480,075 compared with DKK 574,647 the year before. That is an increase of 26.9% compared with the year before. Equity in the 2020 report amounted to DKK 447,463. The solvency ratio was 62.2%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 1,013,451
- Profit/Loss
- DKK 480,075
- Equity
- DKK 447,463
- Total Assets
- DKK 719,252
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 1 mio. | 480 t. | 447 t. | 1 |
| 2019 | - | 799 t. | 575 t. | -33 t. | 1 |
| 2018 | - | -104 t. | -420 t. | -607 t. | 1 |
| 2017 | - | 80 t. | -196 t. | -187 t. | - |
How creditworthy is CPH Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of July 15, 2020, Kamran Khasadar is registered as director of CPH Pharma ApS.
As of July 15, 2020, Faizan Khasadar has stepped down as director of CPH Pharma ApS.
CPH Pharma ApS has published its annual report for 2019. Gross profit came to DKK 798,671, and the net result was DKK 574,647.
About CPH Pharma ApS
CPH Pharma ApS is a Danish company of the type Anpartsselskab based in Værløse, founded in 2015. The company is registered under the industry Rådgivende ingeniøraktiviteter inden for produktions- og maskinteknik. The management consists of Kamran Khasadar. The company is owned by Qi Holding APS. The company has 0 employees (2018). In 2025, the company reported a gross profit of DKK 4,432,157 and a net result of DKK 1,881,849 compared with DKK 1,257,143 the year before. Equity in the 2025 report amounted to DKK 3,102,300.